FDA UNTITLED_LETTER - QuVa Pharma, Inc. - September 24, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This UNTITLED LETTER record concerns QuVa Pharma, Inc., with an inspection on September 24, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: QuVa Pharma, Inc.
Inspection Date: September 24, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Frances G. Bormel (Director)

Open in Dashboard

ID · 9807dbff-8897-48ee-bc96-bc877d478daf

Violation Codes9

21 U.S.C. 331(a)21 U.S.C. 331(k)21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 U.S.C. 353b21 U.S.C. 352(f)(1)21 CFR 211.19221 U.S.C. 351(a)(2)(B)21 U.S.C. 355(a)

Full citation text and observation details available on the Dashboard.